Clinical trial
Determination of Tumor SUV by FDG-PET/CT Before and After Cetuximab in Patients With Metastatic Squamous Cell Carcinoma of the Head and Neck
NCT00671437 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Determination of Tumor SUV by FDG-PET/CT Before and After Cetuximab in Patients With Metastatic Squamous Cell Carcinoma of the Head and Neck
- Lead sponsor
- Washington University School of Medicine
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 30, 2008
- Completion date
- August 31, 2015
- Enrollment
- 42 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.